SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-09-006145
Filing Date
2009-02-09
Accepted
2009-02-09 15:34:41
Documents
2
Period of Report
2009-02-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT v139210_8-k.htm 8-K 21524
2 PRESS RELEASE ex99-1.htm EX-99.1 13277
  Complete submission text file 0001144204-09-006145.txt   36670
Mailing Address MIDDLE SECTION, LONGMAO STREET, AREA A LAIYANG WAIXIANGXING INDUSTRIAL PARK LAIYANG CITY, YANTAI F4 710075
Business Address MIDDLE SECTION, LONGMAO STREET, AREA A LAIYANG WAIXIANGXING INDUSTRIAL PARK LAIYANG CITY, YANTAI F4 710075 5619889880
Genesis Pharmaceuticals Enterprises, Inc. (Filer) CIK: 0001091164 (see all company filings)

IRS No.: 651130026 | State of Incorp.: FL | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-53037 | Film No.: 09581157
SIC: 2834 Pharmaceutical Preparations